Traversa Therapeutics Raises $5 Million
Traversa Therapeutics Inc., a La Jolla, Calif.-based provider of RNAi delivery technologies, has raised $5 million in Series B funding. Morningside Venture Investments led the round, and was joined by fellow return backers Mesa Verde Venture Partners. It had previously raised $2 million.
3 April 2009•2 mins read
